Strategic Vaccines LLC

An Alliance to Save Lives

Strategic Vaccines will be domiciled within the Texas A&M Center for Innovation in Advanced Development and Manufacturing (CIADM) to develop the vaccine/therapeutic.

Read More Here

Rapid Response

In order to support America's response to the COVID Pandemic, M7TecGroup teamed up with Flow Pharma and Texas A&M University System to develop and produce, in volume, a T-Cell Synthetic Vaccine and Therapeutic to combat SARS-CoV2 in 2020.

We are Different

Our Vaccine and Therapeutic system is Synthetic and uses peptide platform technology to build immunity or directly attack the Virus's RNA.

We are Safer

T-Cell Vaccines do not contain a live virus;

FDA primate trials are 100% successful.

Our vaccine is Inhaler/Injection available.

Texas A&M CIADM

© 2025 by M7 TecGroup Ltd. Co..